Multiple Myeloma News
April 27, 2024
Top Headlines
Mar. 25, 2024 — New research has found that venetoclax, a medication currently approved for leukemia, has benefits for patients with multiple myeloma when used in combination with another drug. This discovery offers a new avenue of treatment options for the ...
Feb. 9, 2024 — Researchers around the world share results from a novel model that can provide tailored predictions of how individual patients respond to different ...
Sep. 22, 2023 — A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk ...
Sep. 12, 2023 — A ground-breaking study has revealed crucial insights into the role of the histone methyltransferase NSD2 and its epigenetic target PKC-alpha in causing t(4;14) translocated multiple myeloma (MM), a high-risk subtype of blood cancer, to be more ...
Latest Headlines
updated 4:13pm EDT
Jan. 14, 2024 — Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that often precedes multiple myeloma, according to new ...
Sep. 29, 2023 — Patients with multiple myeloma, a blood cancer of plasma cells in the bone marrow, who also have diabetes have a reduced overall survival when ...
Aug. 31, 2023 — Scientists identified mechanisms by which some multiple myelomas become resistant to initially effective T-cell ...
Jan. 26, 2023 — Chemists designed a bottlebrush-shaped nanoparticle that can be loaded with multiple drugs, in ratios that can be easily controlled. Using these particles, the researchers calculated and delivered ...
Dec. 22, 2022 — Researchers have demonstrated that people suffering from blood cancer have a good immune response to COVID-19 vaccinations. Vaccination protects patients with B-cell lymphoma and multiple myeloma ...
Dec. 20, 2022 — In our bones, specialized cells called osteoblasts are responsible for building up bone substance. A team of researchers has now identified an enzyme ...
Dec. 11, 2022 — A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical ...
Sep. 6, 2022 — New CT technology paired with artificial intelligence (AI)-based noise reduction offers superior detection of bone disease associated with multiple myeloma at lower radiation doses than conventional ...
Sep. 1, 2022 — Researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line ...
June 5, 2022 — Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. ...
Earlier Headlines
Nov. 4, 2022 — Researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back ...
May 19, 2022 — A test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this cancer, investigators ...
Apr. 7, 2022 — Chromosomal abnormalities are found in most multiple myeloma (MM) patients. While myeloma patients have generally benefited from the advancement of treatment modalities over the years, the treatment ...
Apr. 6, 2022 — Most immunocompromised people with a blood cancer called multiple myeloma benefited from a third dose of COVID-19 vaccines, a promising sign after it was shown that two doses tended to not be ...
Mar. 1, 2022 — Multiple myeloma, the most common type of bone marrow cancer in Germany, almost always returns, even after initial treatment success. In the majority of cases, the reasons behind this treatment ...
Jan. 12, 2022 — Multiple myeloma is a cancer of the bone marrow, with a life expectancy of less than 5 years post-diagnosis. Proteasome inhibitors, the therapeutic backbone of current treatments, are very effective ...
Oct. 12, 2021 — A researcher has discovered an enzyme that plays a key role in the ability of cancer cells to resist ...
June 25, 2021 — Researchers are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple ...
May 17, 2021 — An international team of researchers has analyzed the function of the histone demethylase KDM5A in multiple myeloma, one of the three major hematological cancers, and clarified the mechanism by which ...